- Home
- TRT vs CRIS Comparison
TRT vs CRIS Comparison
Compare TRT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- CRIS
- Stock Information
- Founded
- TRT 1958
- CRIS 2000
- Country
- TRT United States
- CRIS United States
- Employees
- TRT N/A
- CRIS N/A
- Industry
- TRT Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRT Technology
- CRIS Health Care
- Exchange
- TRT Nasdaq
- CRIS Nasdaq
- Market Cap
- TRT 22.5M
- CRIS 21.3M
- IPO Year
- TRT N/A
- CRIS 2000
- Fundamental
- Price
- TRT $5.78
- CRIS $1.79
- Analyst Decision
- TRT
- CRIS Strong Buy
- Analyst Count
- TRT 0
- CRIS 2
- Target Price
- TRT N/A
- CRIS $16.50
- AVG Volume (30 Days)
- TRT 29.5K
- CRIS 182.7K
- Earning Date
- TRT 05-13-2025
- CRIS 07-31-2025
- Dividend Yield
- TRT N/A
- CRIS N/A
- EPS Growth
- TRT N/A
- CRIS N/A
- EPS
- TRT 0.00
- CRIS N/A
- Revenue
- TRT $35,548,000.00
- CRIS $11,202,000.00
- Revenue This Year
- TRT N/A
- CRIS N/A
- Revenue Next Year
- TRT N/A
- CRIS $9.52
- P/E Ratio
- TRT $1,232.55
- CRIS N/A
- Revenue Growth
- TRT N/A
- CRIS 14.17
- 52 Week Low
- TRT $4.62
- CRIS $1.02
- 52 Week High
- TRT $7.88
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- TRT 61.37
- CRIS 42.05
- Support Level
- TRT $5.22
- CRIS $1.70
- Resistance Level
- TRT $5.80
- CRIS $1.92
- Average True Range (ATR)
- TRT 0.29
- CRIS 0.20
- MACD
- TRT 0.04
- CRIS -0.01
- Stochastic Oscillator
- TRT 97.06
- CRIS 34.69
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.